ZNF397 inhibitors are a specialized group of molecules that target the Zinc Finger Protein 397 (ZNF397), a member of the zinc finger protein family characterized by their zinc finger motifs-small functional domains stabilized by one or more zinc ions that enable the protein to bind to DNA, RNA, or other proteins. ZNF397, like other zinc finger proteins, is thought to be involved in transcriptional regulation, DNA recognition, and repair, as well as various other cellular processes. Inhibitors of ZNF397 are designed to specifically interact with this protein and disrupt its normal function. The inhibitory action may occur through various mechanisms such as obstructing the zinc finger domains from interacting with their target molecules, or by interfering with the protein's ability to dimerize or associate with other essential cofactors, thereby impeding its role in the cellular context.
The identification and development of ZNF397 inhibitors demand a comprehensive understanding of the protein's structure and function. The discovery process often begins with high-throughput screening techniques to identify compounds that exhibit inhibitory activity against ZNF397. Following initial hits, a combination of computational modeling and medicinal chemistry is employed to understand how these compounds interact with the protein at a molecular level. Researchers use structural biology tools, like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, to determine the three-dimensional structure of ZNF397, particularly the configuration of its zinc finger domains. This structural insight is critical for the rational design of inhibitors, as it allows scientists to predict how small molecules might effectively bind to and alter the conformation or function of the zinc finger motifs. Subsequent iterative cycles of compound synthesis, in vitro testing, and structural analysis refine these lead compounds to improve their selectivity and potency for ZNF397 while reducing their affinity for other zinc finger proteins or unrelated targets.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can disrupt DNA methylation patterns, which may influence the DNA binding capacity of zinc finger proteins like ZNF397. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor; by modulating DNA methylation, it can affect DNA binding characteristics of proteins like ZNF397. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Inhibits the proteasome and can disrupt protein-protein interactions, potentially affecting ZNF397 interactions. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can alter protein turnover and influence the stability or interactions of proteins like ZNF397. | ||||||
17-DMAG, Hydrochloride Salt | 467214-21-7 | sc-396751 | 25 mg | $312.00 | ||
An Hsp90 inhibitor that can disrupt protein folding and interactions, which may affect the functionality or stability of ZNF397. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Another Hsp90 inhibitor, potentially affecting protein stability and interactions of ZNF397 within the cell. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Targets bromodomains, disrupting protein-DNA interactions. This can influence transcriptional regulation activities of proteins like ZNF397. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another bromodomain inhibitor, affecting protein-DNA interactions, potentially influencing the transcriptional roles of ZNF397. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Disrupts p53-MDM2 interaction; while not direct, the modulation of the p53 pathway can impact other transcriptional regulators like ZNF397. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $112.00 $273.00 $1564.00 $5205.00 | 9 | |
Disrupts p53-HDM2 interaction, leading to p53 activation, which may indirectly influence the roles or interactions of other proteins like ZNF397. | ||||||